Biologics Process Development, Inc. Company Profile

12:09 EST 14th December 2018 | BioPortfolio

BPD was formed during the summer of 1996 by Scott M. Brown, Ph.D. Dr. Brown received his Ph.D. from UCLA in 1977 and after postdoctoral studies in molecular biology at the University of Colorado, Boulder began his career in the biotechnology industry. Dr. Brown has been responsible for a variety of cloning and expression projects with three different biotechnology companies. Most recently Dr. Brown was a Group Leader in process development at Corvas International, Inc.
Dr. Brown has over twenty years experience in microbial cell culture (bacteria and yeast). The extent of his experience in microbial cell culture ranges from the initial cloning and isolation of high protein expressors, to laboratory scale production of intermediate quantities of protein (up to 1 gram of protein in 2.5 to 20 L fermentors), to large scale expression of "industrial" amounts of protein (up to 200 grams of protein in 1600 L fermentors).


12740 Danielson Ct., Suite F
United States of America


Phone: 858) 486-9850
Fax: (858) 486-9852

News Articles [1085 Associated News Articles listed on BioPortfolio]

WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United ...

WuXi Biologics is a leading global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing Read ...

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...

WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel ...

SHANGHAI, Dec. 9, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development a...

AGC Biologics Announces New Facility

The process development & manufacturing site will contain single-use bioreactors at the 500 and 2000L scale

WuXi Biologics partners with Inhibrx for GMP manufacturing of protein─based therapeutics

WuXi Biologics, a leading global open─access biologics technology platform company offering end─to─end solutions for biologics discovery, development and manufacturing, and Inhibrx, Inc, a bioph...

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

WuXi Biologics Completes its First GMP Campaign

The newly completed clinical manufacturing facility includes process development labs and six production lines

Samsung BioLogics on future expansion: Novel biologics and new JVs, says CEO

The company is considering an expansion beyond biosimilars into novel biologics development, says CEO TH Kim.

PubMed Articles [2346 Associated PubMed Articles listed on BioPortfolio]

Why Biologics and Biosimilars Remain So Expensive: Despite Two Wins for Biosimilars, the Supreme Court's Recent Rulings do not Solve Fundamental Barriers to Competition.

Biologics and biosimilars are medicines made from living cells that treat common and serious diseases such as cancer, diabetes, rheumatoid arthritis, and other inflammatory diseases. They are highly t...

Introduction of a Process Mass Intensity Metric for Biologics.

Biopharmaceuticals (or biologics), large molecule therapeutics typically produced using biotechnology, are a rapidly growing segment of the pharmaceutical market. As such, the environmental footprint ...

Considerations for implementing an informatics system to support biologics drug discovery.

A comprehensive, well-functioning and scientifically aware informatics environment is of the utmost importance in supporting effective drug discovery programs. However, implementing such a system can,...

Quantitative Assessment of Environmental Impact of Biologics Manufacturing Using Process Mass Intensity Analysis.

Process mass intensity (PMI) is a benchmarking metric to evaluate the efficiency of a manufacturing process, which is indicative of the environmental impact of the process. Although this metric is com...

Dosing considerations for inhaled biologics.

The number of biologics in the therapeutic development pipeline is increasing including those delivered though inhalation (Morales, 2017; Fathe, 2016). Biologics comprise a broad variety of complex ma...

Clinical Trials [3377 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [1882 Associated Companies listed on BioPortfolio]

CMC Biologics

CMC Biologics ( is a leading contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing services to clients aroun...

Panlabs Biologics, Inc.

Panlabs Biologics is a worldwide leading contract research organization, offering a full spectrum of fermentation research and development services, such as microbial extracts for the discovery of new...

MSD Biologics (UK) Limited

Avecia Biologics was acquired in February 2010 by MSD, the UK subsidiary of Merck & Co Inc, the world’s second largest pharmaceutical company. MSD Billingham is one of the world's leading contract ...

GT Biologics

GT Biologics is focused on the research and development of Live Biotherapeutics (LBPs) for the treatment of autoimmune diseases. GT Biologics aim to deliver a new class of medicine based on the po...

Accentus Biologics

Accentus: First class specialists in process development and cGMP manufacture of biopharmaceuticals from microbial systems.

More Information about "Biologics Process Development, Inc." on BioPortfolio

We have published hundreds of Biologics Process Development, Inc. news stories on BioPortfolio along with dozens of Biologics Process Development, Inc. Clinical Trials and PubMed Articles about Biologics Process Development, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biologics Process Development, Inc. Companies in our database. You can also find out about relevant Biologics Process Development, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cloning in biology is the process of producing similar populations of genetically identical individuals that occurs in nature when organisms such as bacteria, insects or plants reproduce asexually. Cloning in biotechnology refers to processes used to cre...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record